Ommoleila Molavi

Tabriz University of Medical Sciences

H指数:29

被引数:3,378

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Manipulation of tumor microenvironment by induction of immunogenic cell death and immune check point inhibitors for enhancing the efficacy of cancer treatments

通过诱导免疫原性细胞死亡和免疫检查点抑制剂来调控肿瘤微环境，以增强癌症治疗的效果。

Biomedicine & Pharmacotherapy

IF7.5

2026-02-120

OAAI

Modulating the tumor microenvironment in a mouse model of colon cancer using a combination of HIF-1α inhibitors and Toll-Like Receptor 7 agonists

NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY

IF3.1

2024-11-300

OAAI

Induction of immunogenic cell death and enhancement of the radiation-induced immunogenicity by chrysin in melanoma cancer cells

SCIENTIFIC REPORTS

IF3.9

2024-10-052

OAAI

Epstein-Barr virus-encoded BART9 and BART15 miRNAs are elevated in exosomes of cerebrospinal fluid from relapsing-remitting multiple sclerosis patients

CYTOKINE

IF3.7

2024-07-018

OAAI

Oxidative stress regulation and related metabolic pathways in epithelial-mesenchymal transition of breast cancer stem cells

STEM CELL RESEARCH & THERAPY

IF7.3

2023-11-2821

OAAI

Stimulators of immunogenic cell death for cancer therapy: focusing on natural compounds

用于癌症治疗的免疫原性细胞死亡刺激剂: 关注天然化合物

CANCER CELL INTERNATIONAL

IF6

2023-09-1319

OAAI

Multiplex Analysis of Cerebrospinal Fluid and Serum Exosomes MicroRNAs of Untreated Relapsing Remitting Multiple Sclerosis (RRMS) and Proposing Noninvasive Diagnostic Biomarkers

未经治疗的复发缓解型多发性硬化症 (RRMS) 的脑脊液和血清外泌体MicroRNAs的多重分析，并提出无创诊断生物标志物

NEUROMOLECULAR MEDICINE

IF3.9

2023-04-0516

PRE

Copper (II) complexes with N, S donor pyrazole-based ligands as anticancer agents

BIOMETALS

IF3.6

2022-08-2410

PRE

Evaluation of anti-proliferative activity of Eryngium caucasicum on melanoma cancer cells

BMC COMPLEMENTARY MEDICINE AND THERAPIES

IF3.4

2022-05-148

OAAI

Preparation and characterization of PLGA-PEG-PLGA polymeric nanoparticles for co-delivery of 5-Fluorouracil and Chrysin

用于5-氟尿嘧啶和白杨素共递送的plga-peg-plga聚合物纳米粒的制备与表征

JOURNAL OF BIOMATERIALS SCIENCE-POLYMER EDITION

IF3.6

2020-04-0568

PREAI

Clinical application of immune checkpoints in targeted immunotherapy of prostate cancer

CELLULAR AND MOLECULAR LIFE SCIENCES

IF6.2

2020-01-3154

OAAI

A gene-based anti-angiogenesis therapy as a novel strategy for cancer treatment

基于基因的抗血管生成治疗作为癌症治疗的新策略

LIFE SCIENCES

IF5.1

2019-12-0111

PREAI

Isolation and characterization of a novel scFv antibody fragments specific for Hsp70 as a tumor biomarker

JOURNAL OF CELLULAR BIOCHEMISTRY

IF2.8

2019-04-1811

PREAI

Therapeutic targeting of angiogenesis molecular pathways in angiogenesis-dependent diseases

血管生成依赖性疾病中血管生成分子途径的靶向治疗

BIOMEDICINE & PHARMACOTHERAPY

IF7.5

2019-02-01184

OAAI

Stattic enhances the anti-proliferative effect of docetaxel via the Bax/Bcl-2/cyclin B axis in human cancer cells

PROCESS BIOCHEMISTRY

IF4

2018-06-0113

PREAI

Synthesis and characterization of novel P(HEMA-LA-MADQUAT) micelles for co-delivery of methotrexate and Chrysin in combination cancer chemotherapy

JOURNAL OF BIOMATERIALS SCIENCE-POLYMER EDITION

IF3.6

2018-04-0930

PREAI

CDK9 Regulates Apoptosis of Myoblast Cells by Modulation of microRNA-1 Expression

JOURNAL OF CELLULAR BIOCHEMISTRY

IF2.8

2017-07-1131

PREAI

Micellar nano-carriers for the delivery of STAT3 dimerization inhibitors to melanoma

DRUG DELIVERY AND TRANSLATIONAL RESEARCH

IF5.5

2017-03-1317

PREAI

Silibinin sensitizes chemo-resistant breast cancer cells to chemotherapy

PHARMACEUTICAL BIOLOGY

IF4.8

2016-12-2773

OAAI

Sustained release of melatonin: A novel approach in elevating efficacy of tamoxifen in breast cancer treatment

COLLOIDS AND SURFACES B-BIOINTERFACES

IF5.6

2016-09-0176

PREAI

Ommoleila Molavi

个人简介

教育背景

工作经历

荣誉奖项

研究方向